|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Cara Therapeutics Inc. (CARA)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-05-28 Sale |
2019-05-30 6:19 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
2,303 | $21.38 | $49,238 | 14,719 (Direct) |
View |
| 2019-05-28 Sale |
2019-05-30 6:18 pm |
Cara Therapeutics Inc. | CARA | CHALMERS DEREK T CEO |
5,528 | $21.42 | $118,410 | 963,996 (Direct) |
View |
| 2019-05-28 Sale |
2019-05-30 6:17 pm |
Cara Therapeutics Inc. | CARA | Mohindru Mani CFO |
2,496 | $21.39 | $53,389 | 16,359 (Direct) |
View |
| 2019-05-28 Sale |
2019-05-30 6:16 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
11,397 | $21.19 | $241,502 | 160,279 (Direct) |
View |
| 2019-03-13 Sale |
2019-03-15 4:42 pm |
Cara Therapeutics Inc. | CARA | Mohindru Mani CFO |
16,041 | $19.12 | $306,704 | 336,875 (Direct) |
View |
| 2019-03-12 Sale |
2019-03-14 5:13 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
20,000 | $18.65 | $373,020 | 139,582 (Direct) |
View |
| 2019-03-01 Sale |
2019-03-05 4:53 pm |
Cara Therapeutics Inc. | CARA | CHALMERS DEREK T CEO |
9,792 | $17.04 | $166,856 | 943,996 (Direct) |
View |
| 2019-02-28 Sale |
2019-03-04 5:49 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. VP |
1,500 | $17.5 | $26,250 | 142,779 (Direct) |
View |
| 2019-02-25 Sale |
2019-02-27 5:29 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. VP |
2,200 | $17.5 | $38,500 | 144,279 (Direct) |
View |
| 2019-02-01 Sale |
2019-02-05 4:27 pm |
Cara Therapeutics Inc. | CARA | CHALMERS DEREK T CEO |
20,000 | $14.99 | $299,800 | 953,788 (Direct) |
View |
| 2019-01-02 Sale |
2019-01-04 4:22 pm |
Cara Therapeutics Inc. | CARA | CHALMERS DEREK T CEO |
20,000 | $13.61 | $272,150 | 978,788 (Direct) |
View |
| 2018-12-28 Sale |
2019-01-02 5:56 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. VP |
4,300 | $12.53 | $53,879 | 146,479 (Direct) |
View |
| 2018-12-28 Sale |
2019-01-02 5:56 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
3,100 | $12.51 | $38,781 | 6,386 (Direct) |
View |
| 2018-12-28 Sale |
2019-01-02 5:55 pm |
Cara Therapeutics Inc. | CARA | CHALMERS DEREK T CEO |
15,825 | $12.53 | $198,287 | 993,788 (Direct) |
View |
| 2018-12-28 Sale |
2019-01-02 5:54 pm |
Cara Therapeutics Inc. | CARA | Mohindru Mani CFO |
4,500 | $12.55 | $56,475 | 8,026 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-06 4:18 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. VP |
3,000 | $18.36 | $55,080 | 139,000 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-06 4:16 pm |
Cara Therapeutics Inc. | CARA | CHALMERS DEREK T CEO |
20,000 | $18.17 | $363,400 | 971,392 (Direct) |
View |
| 2018-11-15 Sale |
2018-11-16 4:22 pm |
Cara Therapeutics Inc. | CARA | Mohindru Mani CFO |
16,042 | $18.5 | $296,777 | 352,916 (Direct) |
View |
| 2018-11-01 Sale |
2018-11-05 8:25 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. VP |
3,000 | $18.77 | $56,310 | 145,000 (Direct) |
View |
| 2018-11-01 Sale |
2018-11-02 5:35 pm |
Cara Therapeutics Inc. | CARA | CHALMERS DEREK T CEO |
20,000 | $18.78 | $375,600 | 991,392 (Direct) |
View |
| 2018-10-17 Sale |
2018-10-19 4:34 pm |
Cara Therapeutics Inc. | CARA | Stauffer Joseph William Chief Medical Officer |
11,442 | $20.13 | $230,347 | 2,970 (Direct) |
View |
| 2018-10-17 Sale |
2018-10-19 4:32 pm |
Cara Therapeutics Inc. | CARA | Mohindru Mani CFO |
16,042 | $20.19 | $323,888 | 368,958 (Direct) |
View |
| 2018-10-01 Sale |
2018-10-03 4:09 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. VP |
3,000 | $23.99 | $71,970 | 95,000 (Direct) |
View |
| 2018-10-01 Sale |
2018-10-03 4:08 pm |
Cara Therapeutics Inc. | CARA | CHALMERS DEREK T CEO |
20,000 | $23.79 | $475,800 | 1,011,392 (Direct) |
View |
| 2018-09-04 Sale |
2018-09-06 5:34 pm |
Cara Therapeutics Inc. | CARA | CHALMERS DEREK T CEO |
20,000 | $19.71 | $394,200 | 1,031,392 (Direct) |
View |
| 2018-09-04 Sale |
2018-09-06 5:33 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. VP |
3,000 | $19.81 | $59,430 | 98,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-06-04 Option Award |
2019-06-06 6:04 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | VOGELBAUM MARTIN Director |
6,000 | $0 | 3,068,057 (Direct) |
View |
| 2019-06-04 Option Award |
2019-06-06 6:04 pm |
N/A 2029-06-04 |
Cara Therapeutics Inc. | CARA | VOGELBAUM MARTIN Director |
9,000 | $20.44 | 3,068,057 (Direct) |
View |
| 2019-06-04 Option Award |
2019-06-06 6:03 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Posner Christopher Director |
6,000 | $0 | 9,000 (Direct) |
View |
| 2019-06-04 Option Award |
2019-06-06 6:03 pm |
N/A 2029-06-04 |
Cara Therapeutics Inc. | CARA | Posner Christopher Director |
9,000 | $20.44 | 9,000 (Direct) |
View |
| 2019-06-04 Option Award |
2019-06-06 6:01 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Ives Jeffrey L. Director |
6,000 | $0 | 9,000 (Direct) |
View |
| 2019-06-04 Option Award |
2019-06-06 6:01 pm |
N/A 2029-06-04 |
Cara Therapeutics Inc. | CARA | Ives Jeffrey L. Director |
9,000 | $20.44 | 9,000 (Direct) |
View |
| 2019-06-04 Option Award |
2019-06-06 6:00 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | BAINS HARRISON M JR Director |
6,000 | $0 | 9,000 (Direct) |
View |
| 2019-06-04 Option Award |
2019-06-06 6:00 pm |
N/A 2029-06-04 |
Cara Therapeutics Inc. | CARA | BAINS HARRISON M JR Director |
9,000 | $20.44 | 9,000 (Direct) |
View |
| 2019-05-28 Option Award |
2019-05-30 6:19 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
8,333 | $0 | 14,719 (Direct) |
View |
| 2019-05-28 Option Award |
2019-05-30 6:18 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | CHALMERS DEREK T CEO |
20,000 | $0 | 963,996 (Direct) |
View |
| 2019-05-28 Option Award |
2019-05-30 6:17 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Mohindru Mani CFO |
8,333 | $0 | 16,359 (Direct) |
View |
| 2019-05-28 Option Award |
2019-05-30 6:16 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
37,500 | $0 | 160,279 (Direct) |
View |
| 2019-03-13 Exercise |
2019-03-15 4:42 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Mohindru Mani CFO |
16,041 | $14.06 | 336,875 (Direct) |
View |
| 2019-03-13 Exercise |
2019-03-15 4:42 pm |
N/A 2027-08-15 |
Cara Therapeutics Inc. | CARA | Mohindru Mani CFO |
16,041 | $14.06 | 336,875 (Direct) |
View |
| 2019-03-06 Option Award |
2019-03-08 5:33 pm |
N/A 2029-03-06 |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
150,000 | $16.1 | 150,000 (Direct) |
View |
| 2019-03-06 Option Award |
2019-03-08 5:32 pm |
N/A 2029-03-06 |
Cara Therapeutics Inc. | CARA | Mohindru Mani CFO |
75,000 | $16.1 | 75,000 (Direct) |
View |
| 2019-03-06 Option Award |
2019-03-08 5:32 pm |
N/A 2029-03-06 |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
75,000 | $16.1 | 75,000 (Direct) |
View |
| 2019-03-06 Option Award |
2019-03-08 5:31 pm |
N/A 2029-03-06 |
Cara Therapeutics Inc. | CARA | CHALMERS DEREK T CEO |
235,000 | $16.1 | 235,000 (Direct) |
View |
| 2018-12-27 Option Award |
2018-12-31 4:19 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
9,486 | $0 | 9,486 (Direct) |
View |
| 2018-12-27 Option Award |
2018-12-31 4:18 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. VP |
11,779 | $0 | 150,779 (Direct) |
View |
| 2018-12-27 Option Award |
2018-12-31 4:17 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Mohindru Mani CFO |
12,526 | $0 | 12,526 (Direct) |
View |
| 2018-12-27 Option Award |
2018-12-31 4:15 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | CHALMERS DEREK T CEO |
38,221 | $0 | 1,009,613 (Direct) |
View |
| 2018-11-15 Exercise |
2018-11-16 4:22 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Mohindru Mani CFO |
16,042 | $14.06 | 352,916 (Direct) |
View |
| 2018-11-15 Exercise |
2018-11-16 4:22 pm |
N/A 2027-08-15 |
Cara Therapeutics Inc. | CARA | Mohindru Mani CFO |
16,042 | $14.06 | 352,916 (Direct) |
View |
| 2018-11-01 Exercise |
2018-11-05 8:25 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. VP |
40,000 | $2.05 | 145,000 (Direct) |
View |
| 2018-11-01 Exercise |
2018-11-05 8:25 pm |
N/A 2020-10-15 |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. VP |
40,000 | $2.05 | 145,000 (Direct) |
View |
| 2018-08-06 Exercise |
2018-11-05 8:21 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. VP |
10,000 | $2.25 | 114,000 (Direct) |
View |
| 2018-08-06 Exercise |
2018-11-05 8:21 pm |
N/A 2018-08-14 |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. VP |
10,000 | $2.25 | 114,000 (Direct) |
View |
| 2018-10-22 Option Award |
2018-10-24 4:32 pm |
N/A 2028-10-22 |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
250,000 | $19.27 | 250,000 (Direct) |
View |
| 2018-10-17 Exercise |
2018-10-19 4:32 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Mohindru Mani CFO |
16,042 | $14.06 | 368,958 (Direct) |
View |
| 2018-10-17 Exercise |
2018-10-19 4:32 pm |
N/A 2027-08-15 |
Cara Therapeutics Inc. | CARA | Mohindru Mani CFO |
16,042 | $14.06 | 368,958 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Tue, 25 Jun 2019 11:39:11 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |